PIXEL / USDC

STO / TRY

STO / USDT

PIXEL / TRY

STO / USDC

PIXEL / USDT

SOLV / BNB

SOLV / TRY

SOLV / USDT

REZ / USDT

KITE / TRY

KITE / USDT

KITE / USDC

KERNEL / TRY

CTSI / USDT

KERNEL / USDT

KERNEL / USDC

NOM / USDT

NOM / TRY

CTSI / BTC

RUCHI INFRASTRUCTURE LTD

PRANIK LOGISTICS LIMITED

GSS INFOTECH LIMITED

BOMBAY SUPER HYBRID SEEDS

BROOKS LAB LIMITED

CONFIDENCE PETRO IND LTD.

LATENT VIEW ANALYTICS LTD

ORIENTAL TRIMEX LTD

ATC ENERGIES SYSTEM LTD

HLV LIMITED

R&B DENIMS LIMITED

AVG LOGISTICS LIMITED

MAHA RASHTRA APEX COPR. L

CURIS LIFESCIENCES LTD

HILTON METAL FORGING LTD

ACUTAAS CHEMICALS LIMITED

SUPREME HOLDIN N HOSP I L

SHIVASHRIT FOODS LIMITED

SILKY OVERSEAS LIMITED

KAUSHALYA LOGISTICS LTD

Click here to get full coverage on SMS Pharma Faces Rs 7.19 Crore Tax Demand in Income Under-Reporting Case - A2Z Taxcorp LLP

SMS Pharma Faces Rs 7.19 Crore Tax Demand in Income Under-Reporting Case  A2Z Taxcorp LLP

SMS Pharma Faces Rs 7.19 Crore Tax Demand in Income Under-Reporting Case - A2Z Taxcorp LLP

Click here to get full coverage on SMS Pharmaceuticals' (NSE:SMSPHARMA) Solid Profits Have Weak Fundamentals - simplywall.st

SMS Pharmaceuticals' (NSE:SMSPHARMA) Solid Profits Have Weak Fundamentals  simplywall.st

SMS Pharmaceuticals' (NSE:SMSPHARMA) Solid Profits Have Weak Fundamentals - simplywall.st

Click here to get full coverage on SMS Pharma Faces Rs 7.19 Crore Tax Demand in Income Under-Reporting Case - Medical Dialogues

SMS Pharma Faces Rs 7.19 Crore Tax Demand in Income Under-Reporting Case  Medical Dialogues

SMS Pharma Faces Rs 7.19 Crore Tax Demand in Income Under-Reporting Case - Medical Dialogues

Click here to get full coverage on SMS Pharma Shares Surge 12% on 74% Profit Jump in Q2FY26 - HDFC Sky

SMS Pharma Shares Surge 12% on 74% Profit Jump in Q2FY26  HDFC Sky

SMS Pharma Shares Surge 12% on 74% Profit Jump in Q2FY26 - HDFC Sky

Click here to get full coverage on SMS Pharma up 8% as arm gets USFDA nod for reformulated Ranitidine tablets - Business Standard

SMS Pharma up 8% as arm gets USFDA nod for reformulated Ranitidine tablets  Business Standard

SMS Pharma up 8% as arm gets USFDA nod for reformulated Ranitidine tablets - Business Standard

Click here to get full coverage on SMS Pharma gains 18% on U.S FDA nod for reformulated Ranitidine of associate firm - The Hindu

SMS Pharma gains 18% on U.S FDA nod for reformulated Ranitidine of associate firm  The Hindu

SMS Pharma gains 18% on U.S FDA nod for reformulated Ranitidine of associate firm - The Hindu

Click here to get full coverage on Market Participants Recognise SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Earnings Pushing Shares 31% Higher - simplywall.st

Market Participants Recognise SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Earnings Pushing Shares 31% Higher  simplywall.st

Market Participants Recognise SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Earnings Pushing Shares 31% Higher - simplywall.st

Click here to get full coverage on SMS Pharma’s associate firm gets USFDA nod for Ranitidine tablets - BusinessLine

SMS Pharma’s associate firm gets USFDA nod for Ranitidine tablets  BusinessLine

SMS Pharma’s associate firm gets USFDA nod for Ranitidine tablets - BusinessLine

Click here to get full coverage on SMS Pharmaceuticals Ltd: Valuation Shift Signals Price Attractiveness Amid Sector Dynamics - Markets Mojo

SMS Pharmaceuticals Ltd: Valuation Shift Signals Price Attractiveness Amid Sector Dynamics  Markets Mojo

SMS Pharmaceuticals Ltd: Valuation Shift Signals Price Attractiveness Amid Sector Dynamics - Markets Mojo

Click here to get full coverage on SMS Pharma Shares Skyrocket 10% on EIR from USFDA - Equitypandit

SMS Pharma Shares Skyrocket 10% on EIR from USFDA  Equitypandit

SMS Pharma Shares Skyrocket 10% on EIR from USFDA - Equitypandit

Click here to get full coverage on FDA completes inspection of SMS Pharma’s Vizag facility - Indian Pharma Post

FDA completes inspection of SMS Pharma’s Vizag facility  Indian Pharma Post

FDA completes inspection of SMS Pharma’s Vizag facility - Indian Pharma Post

Click here to get full coverage on SMS Pharmaceuticals shares soar 17% after USFDA approves reformulated Ranitidine tablets - livemint.com

SMS Pharmaceuticals shares soar 17% after USFDA approves reformulated Ranitidine tablets  livemint.com

SMS Pharmaceuticals shares soar 17% after USFDA approves reformulated Ranitidine tablets - livemint.com

Click here to get full coverage on Buzzing Stocks: Drugmaker gains most in five years after regulator approves re-entry of key drug - CNBC TV18

Buzzing Stocks: Drugmaker gains most in five years after regulator approves re-entry of key drug  CNBC TV18

Buzzing Stocks: Drugmaker gains most in five years after regulator approves re-entry of key drug - CNBC TV18

Click here to get full coverage on SMS Pharma Shares Rise On USFDA Ranitidine Approval - Samco

SMS Pharma Shares Rise On USFDA Ranitidine Approval  Samco

SMS Pharma Shares Rise On USFDA Ranitidine Approval - Samco

Click here to get full coverage on SMS Pharma Q3 Profit Soars 36%, Invests ₹7 Cr in Unit - whalesbook.com

SMS Pharma Q3 Profit Soars 36%, Invests ₹7 Cr in Unit  whalesbook.com

SMS Pharma Q3 Profit Soars 36%, Invests ₹7 Cr in Unit - whalesbook.com

Click here to get full coverage on SMS Pharma Surges 10% on USFDA Nod, Ends 3.85% Lower - HDFC Sky

SMS Pharma Surges 10% on USFDA Nod, Ends 3.85% Lower  HDFC Sky

SMS Pharma Surges 10% on USFDA Nod, Ends 3.85% Lower - HDFC Sky

Click here to get full coverage on Sharda Crop, SMS Pharma among top analyst bets; check target, stop-loss - Business Standard

Sharda Crop, SMS Pharma among top analyst bets; check target, stop-loss  Business Standard

Sharda Crop, SMS Pharma among top analyst bets; check target, stop-loss - Business Standard

Click here to get full coverage on SMS Pharmaceuticals Share Price - HDFC Sky

SMS Pharmaceuticals Share Price  HDFC Sky

SMS Pharmaceuticals Share Price - HDFC Sky

Click here to get full coverage on SMS Pharma spurts after Q2 PAT climbs 79% YoY to Rs 25 cr - Business Standard

SMS Pharma spurts after Q2 PAT climbs 79% YoY to Rs 25 cr  Business Standard

SMS Pharma spurts after Q2 PAT climbs 79% YoY to Rs 25 cr - Business Standard

Click here to get full coverage on SMS Pharma spurts after associate firm secures USFDA nod for reformulated Ranitidine tablets - Business Standard

SMS Pharma spurts after associate firm secures USFDA nod for reformulated Ranitidine tablets  Business Standard

SMS Pharma spurts after associate firm secures USFDA nod for reformulated Ranitidine tablets - Business Standard

Click here to get full coverage on SMS Pharma Shares Skyrocketed 17% as Arm Secured USFDA Approval - Equitypandit

SMS Pharma Shares Skyrocketed 17% as Arm Secured USFDA Approval  Equitypandit

SMS Pharma Shares Skyrocketed 17% as Arm Secured USFDA Approval - Equitypandit

Click here to get full coverage on Stocks to Watch Today: Lotus Developers, InterGlobe, SMS Pharma, E2E Networks, Mangal Electrical, HFCL,... - Moneycontrol.com

Stocks to Watch Today: Lotus Developers, InterGlobe, SMS Pharma, E2E Networks, Mangal Electrical, HFCL,...  Moneycontrol.com

Stocks to Watch Today: Lotus Developers, InterGlobe, SMS Pharma, E2E Networks, Mangal Electrical, HFCL,... - Moneycontrol.com

Click here to get full coverage on SMS Pharma successfully completes USFDA inspection at Telangana Central Laboratory Analytical Services - Medical Dialogues

SMS Pharma successfully completes USFDA inspection at Telangana Central Laboratory Analytical Services  Medical Dialogues

SMS Pharma successfully completes USFDA inspection at Telangana Central Laboratory Analytical Services - Medical Dialogues

Click here to get full coverage on SMS Pharma Shares Surge 6% on 0 Observations from USFDA - Equitypandit

SMS Pharma Shares Surge 6% on 0 Observations from USFDA  Equitypandit

SMS Pharma Shares Surge 6% on 0 Observations from USFDA - Equitypandit

Click here to get full coverage on SMS Pharma's Hyderabad Lab Receives FDA Clearance with 'No Action Indicated' Status - scanx.trade

SMS Pharma's Hyderabad Lab Receives FDA Clearance with 'No Action Indicated' Status  scanx.trade

SMS Pharma's Hyderabad Lab Receives FDA Clearance with 'No Action Indicated' Status - scanx.trade

Click here to get full coverage on SMS Pharma Consolidated September 2025 Net Sales at Rs 242.43 crore, up 23.22% Y-o-Y - Moneycontrol.com

SMS Pharma Consolidated September 2025 Net Sales at Rs 242.43 crore, up 23.22% Y-o-Y  Moneycontrol.com

SMS Pharma Consolidated September 2025 Net Sales at Rs 242.43 crore, up 23.22% Y-o-Y - Moneycontrol.com

Click here to get full coverage on SMS Pharma Surges on 21% Revenue Growth, Margin Boost from Integration - whalesbook.com

SMS Pharma Surges on 21% Revenue Growth, Margin Boost from Integration  whalesbook.com

SMS Pharma Surges on 21% Revenue Growth, Margin Boost from Integration - whalesbook.com

Click here to get full coverage on SMS Pharma Standalone December 2025 Net Sales at Rs 210.45 crore, up 21.4% Y-o-Y - Moneycontrol.com

SMS Pharma Standalone December 2025 Net Sales at Rs 210.45 crore, up 21.4% Y-o-Y  Moneycontrol.com

SMS Pharma Standalone December 2025 Net Sales at Rs 210.45 crore, up 21.4% Y-o-Y - Moneycontrol.com

Click here to get full coverage on Sms Pharmaceuticals Stock Price Forecast. Should You Buy SMSPHARMA.NS? - StockInvest.us

Sms Pharmaceuticals Stock Price Forecast. Should You Buy SMSPHARMA.NS?  StockInvest.us

Sms Pharmaceuticals Stock Price Forecast. Should You Buy SMSPHARMA.NS? - StockInvest.us

Click here to get full coverage on SMS Pharma Sees Revision in Market Evaluation Amidst Strong Financial Indicators - Markets Mojo

SMS Pharma Sees Revision in Market Evaluation Amidst Strong Financial Indicators  Markets Mojo

SMS Pharma Sees Revision in Market Evaluation Amidst Strong Financial Indicators - Markets Mojo

Click here to get full coverage on SMS Pharma Receives 'No Action Indicated' Status from USFDA for Hyderabad Laboratory - scanx.trade

SMS Pharma Receives 'No Action Indicated' Status from USFDA for Hyderabad Laboratory  scanx.trade

SMS Pharma Receives 'No Action Indicated' Status from USFDA for Hyderabad Laboratory - scanx.trade

Click here to get full coverage on SMS Pharmaceuticals Q2 | Profit rises 76% YoY to ₹25.14 crore on operational performance - CNBC TV18

SMS Pharmaceuticals Q2 | Profit rises 76% YoY to ₹25.14 crore on operational performance  CNBC TV18

SMS Pharmaceuticals Q2 | Profit rises 76% YoY to ₹25.14 crore on operational performance - CNBC TV18

Click here to get full coverage on Vistra ITCL Releases 1.06 Crore Pledged Shares of SMS Pharmaceuticals - scanx.trade

Vistra ITCL Releases 1.06 Crore Pledged Shares of SMS Pharmaceuticals  scanx.trade

Vistra ITCL Releases 1.06 Crore Pledged Shares of SMS Pharmaceuticals - scanx.trade

Click here to get full coverage on SMSPHARMA Stock Price and Chart — NSE:SMSPHARMA - TradingView

SMSPHARMA Stock Price and Chart — NSE:SMSPHARMA  TradingView

SMSPHARMA Stock Price and Chart — NSE:SMSPHARMA - TradingView

Click here to get full coverage on SMSPHARMA Share Price | SMS Pharmaceuticals Ltd Stock Analysis & Recommendation - Markets Mojo

SMSPHARMA Share Price | SMS Pharmaceuticals Ltd Stock Analysis & Recommendation  Markets Mojo

SMSPHARMA Share Price | SMS Pharmaceuticals Ltd Stock Analysis & Recommendation - Markets Mojo

Click here to get full coverage on SMS Pharmaceuticals Ltd Hits Intraday High with 9.32% Surge on 12 Feb 2026 - Markets Mojo

SMS Pharmaceuticals Ltd Hits Intraday High with 9.32% Surge on 12 Feb 2026  Markets Mojo

SMS Pharmaceuticals Ltd Hits Intraday High with 9.32% Surge on 12 Feb 2026 - Markets Mojo

Click here to get full coverage on SMS Pharmaceuticals Gets USFDA Clearance for Hyderabad Lab With NAI Status - India Infoline

SMS Pharmaceuticals Gets USFDA Clearance for Hyderabad Lab With NAI Status  India Infoline

SMS Pharmaceuticals Gets USFDA Clearance for Hyderabad Lab With NAI Status - India Infoline

Click here to get full coverage on Trade Spotlight: How should you trade Lupin, IIFL Finance, Max Financial Services, Adani Ports, SMS... - Moneycontrol.com

Trade Spotlight: How should you trade Lupin, IIFL Finance, Max Financial Services, Adani Ports, SMS...  Moneycontrol.com

Trade Spotlight: How should you trade Lupin, IIFL Finance, Max Financial Services, Adani Ports, SMS... - Moneycontrol.com

Click here to get full coverage on SMS Pharma Visakhapatnam facility gets WHO Geneva prequalification - Medical Dialogues

SMS Pharma Visakhapatnam facility gets WHO Geneva prequalification  Medical Dialogues

SMS Pharma Visakhapatnam facility gets WHO Geneva prequalification - Medical Dialogues

Click here to get full coverage on Read This Before You Buy SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Because Of Its P/E Ratio - malaysia.news.yahoo.com

Read This Before You Buy SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Because Of Its P/E Ratio  malaysia.news.yahoo.com

Read This Before You Buy SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Because Of Its P/E Ratio - malaysia.news.yahoo.com

Click here to get full coverage on SMS Pharmaceuticals Reports 19% Revenue Growth and 24% PAT Increase in Q1 - scanx.trade

SMS Pharmaceuticals Reports 19% Revenue Growth and 24% PAT Increase in Q1  scanx.trade

SMS Pharmaceuticals Reports 19% Revenue Growth and 24% PAT Increase in Q1 - scanx.trade

Click here to get full coverage on Technical Analysis of SMS Pharmaceuticals Limited (NSE:SMSPHARMA) - TradingView

Technical Analysis of SMS Pharmaceuticals Limited (NSE:SMSPHARMA)  TradingView

Technical Analysis of SMS Pharmaceuticals Limited (NSE:SMSPHARMA) - TradingView

Click here to get full coverage on SMS Pharmaceuticals Lists 5 Crore Equity Shares from Warrant Conversion on BSE and NSE - scanx.trade

SMS Pharmaceuticals Lists 5 Crore Equity Shares from Warrant Conversion on BSE and NSE  scanx.trade

SMS Pharmaceuticals Lists 5 Crore Equity Shares from Warrant Conversion on BSE and NSE - scanx.trade

Click here to get full coverage on Pharma stock jumps 10% after USFDA clears company's Hyderabad facility with zero observations - Trade Brains

Pharma stock jumps 10% after USFDA clears company's Hyderabad facility with zero observations  Trade Brains

Pharma stock jumps 10% after USFDA clears company's Hyderabad facility with zero observations - Trade Brains

Click here to get full coverage on SMS Pharmaceuticals’ Vizag plant receives WHO Geneva prequalification - Indian Pharma Post

SMS Pharmaceuticals’ Vizag plant receives WHO Geneva prequalification  Indian Pharma Post

SMS Pharmaceuticals’ Vizag plant receives WHO Geneva prequalification - Indian Pharma Post

Click here to get full coverage on Watch out for these 20 stocks in today’s trade: Hindustan Unilever, PB Fintech, Mobikwik, ONGC, Wheels India, Texmaco Rail, JSW Steel, JSW Energy, NHPC, Tejas Networks, SMS Pharma, Balaji Amines, Adani Total, Signatureglobal, Western Carriers, Solari - BusinessLine

Watch out for these 20 stocks in today’s trade: Hindustan Unilever, PB Fintech, Mobikwik, ONGC, Wheels India, Texmaco Rail, JSW Steel, JSW Energy, NHPC, Tejas Networks, SMS Pharma, Balaji Amines, Adani Total, Signatureglobal, Western Carriers, Solari  BusinessLine

Watch out for these 20 stocks in today’s trade: Hindustan Unilever, PB Fintech, Mobikwik, ONGC, Wheels India, Texmaco Rail, JSW Steel, JSW Energy, NHPC, Tejas Networks, SMS Pharma, Balaji Amines, Adani Total, Signatureglobal, Western Carriers, Solari - BusinessLine

Click here to get full coverage on SMS Pharma receives EDQM certification to supply Ibuprofen in Europe - Indian Pharma Post

SMS Pharma receives EDQM certification to supply Ibuprofen in Europe  Indian Pharma Post

SMS Pharma receives EDQM certification to supply Ibuprofen in Europe - Indian Pharma Post

Click here to get full coverage on SMS Pharma’s Vizag plant receives WHO prequalification - The Hindu

SMS Pharma’s Vizag plant receives WHO prequalification  The Hindu

SMS Pharma’s Vizag plant receives WHO prequalification - The Hindu

Click here to get full coverage on SMS Pharma gets one USFDA observation for Bachupally facility - Medical Dialogues

SMS Pharma gets one USFDA observation for Bachupally facility  Medical Dialogues

SMS Pharma gets one USFDA observation for Bachupally facility - Medical Dialogues

Click here to get full coverage on SMS Pharma revenue down 9% - Indian Pharma Post

SMS Pharma revenue down 9%  Indian Pharma Post

SMS Pharma revenue down 9% - Indian Pharma Post

Click here to get full coverage on SMS Pharmaceuticals Q2 Results 2026 - Find SMS Pharmaceuticals Q2 Earnings Result | SMSPHARMA Q2 results - livemint.com

SMS Pharmaceuticals Q2 Results 2026 - Find SMS Pharmaceuticals Q2 Earnings Result | SMSPHARMA Q2 results  livemint.com

SMS Pharmaceuticals Q2 Results 2026 - Find SMS Pharmaceuticals Q2 Earnings Result | SMSPHARMA Q2 results - livemint.com

Click here to get full coverage on SMS Pharma to raise ₹114 crore through warrants issue - BusinessLine

SMS Pharma to raise ₹114 crore through warrants issue  BusinessLine

SMS Pharma to raise ₹114 crore through warrants issue - BusinessLine

Click here to get full coverage on SMS Pharma reports on USFDA articulation on Ranitidine - Microbioz India

SMS Pharma reports on USFDA articulation on Ranitidine  Microbioz India

SMS Pharma reports on USFDA articulation on Ranitidine - Microbioz India

Click here to get full coverage on SMS Pharmaceuticals Share Price Today - Live SMSPHARMA Stock Price for NSE/BSE - Upstox

SMS Pharmaceuticals Share Price Today - Live SMSPHARMA Stock Price for NSE/BSE  Upstox

SMSPHARMA

Price Chart

Key Statistics

Technicals

About SMSPHARMA

Latest News

SMS Pharma Faces Rs 7.19 Crore Tax Demand in Income Under-Reporting Case - A2Z Taxcorp LLP

SMS Pharmaceuticals' (NSE:SMSPHARMA) Solid Profits Have Weak Fundamentals - simplywall.st

SMS Pharma Faces Rs 7.19 Crore Tax Demand in Income Under-Reporting Case - Medical Dialogues

Advanced Charts

Top Gainers

Top Losers